The number of new cases of systemic sclerosis (SSc) is on the rise in Quebec, particularly among children, a new study has found.
Systemic sclerosis is on the rise in Quebec, especially in children, study finds retrieved 10 July 2024 from https://medicalxpress.com/news/2024-07-sclerosis-quebec-children.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Tesla sued for 'systemic' racism at its Fremont, California plantCampus faces yet another racial discrimination lawsuit as Clean Air Act violations claims also hit the fan
Read more »
Researchers test the systemic score for Still's diseaseStill's disease is an inflammatory disorder typically manifesting with fever, arthritis, and skin rash. It affects both children and adults, and has previously been known as systemic juvenile idiopathic arthritis and adult-onset Still's disease. Regardless of the name, people with Still's disease are burdened by life-threatening complications.
Read more »
Dose reduction of glucocorticoids in systemic lupus erythematosusGlucocorticoids are a mainstay of treatment for systemic lupus erythematosus (SLE). But due to long-term adverse effects, dose reduction is becoming a crucial part of treat-to-target management goals.
Read more »
Low-dose glucocorticoids in systemic lupus erythematosus: New evidence around use and thresholdsGlucocorticoids are a mainstay of treatment for systemic lupus erythematosus (SLE). But due to long-term adverse effects, dose reduction is becoming a crucial part of treat-to-target management goals. However, data regarding the optimum dose target is conflicting.
Read more »
Unpicking the complexity of systemic sclerosisIn 2023, The European Alliance of Associations for Rheumatology(EULAR) updated its recommendations for the treatment of systemic sclerosis (SSc), with many new inclusions around manifestations such as skin fibrosis and interstitial lung disease (ILD).
Read more »
Identifying predictors for organ damage in children with systemic lupus erythematosusChildhood-onset systemic lupus erythematosus (cSLE) is a chronic, severe autoimmune disorder that carries a risk of early organ damage. Identifying specific predictors in children is vital for preventing such damage.
Read more »